- Home
- PETZ vs BMRA Comparison
PETZ vs BMRA Comparison
Compare PETZ & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- BMRA
- Stock Information
- Founded
- PETZ 2002
- BMRA 1971
- Country
- PETZ China
- BMRA United States
- Employees
- PETZ N/A
- BMRA N/A
- Industry
- PETZ Steel/Iron Ore
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PETZ Industrials
- BMRA Health Care
- Exchange
- PETZ Nasdaq
- BMRA Nasdaq
- Market Cap
- PETZ 12.9M
- BMRA 11.2M
- IPO Year
- PETZ 2017
- BMRA N/A
- Fundamental
- Price
- PETZ $1.11
- BMRA $0.57
- Analyst Decision
- PETZ
- BMRA
- Analyst Count
- PETZ 0
- BMRA 0
- Target Price
- PETZ N/A
- BMRA N/A
- AVG Volume (30 Days)
- PETZ 8.7K
- BMRA 187.3K
- Earning Date
- PETZ 04-28-2025
- BMRA 04-11-2025
- Dividend Yield
- PETZ N/A
- BMRA N/A
- EPS Growth
- PETZ N/A
- BMRA N/A
- EPS
- PETZ N/A
- BMRA N/A
- Revenue
- PETZ $3,278,453.00
- BMRA $5,578,000.00
- Revenue This Year
- PETZ N/A
- BMRA N/A
- Revenue Next Year
- PETZ N/A
- BMRA N/A
- P/E Ratio
- PETZ N/A
- BMRA N/A
- Revenue Growth
- PETZ 2.46
- BMRA 1.40
- 52 Week Low
- PETZ $1.03
- BMRA $0.24
- 52 Week High
- PETZ $1.74
- BMRA $1.27
- Technical
- Relative Strength Index (RSI)
- PETZ 32.84
- BMRA 40.83
- Support Level
- PETZ $1.10
- BMRA $0.55
- Resistance Level
- PETZ $1.41
- BMRA $0.74
- Average True Range (ATR)
- PETZ 0.09
- BMRA 0.05
- MACD
- PETZ -0.03
- BMRA -0.01
- Stochastic Oscillator
- PETZ 3.23
- BMRA 9.84
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling of petfood and restaurant operations. The company has two operating segments which include Petfood sales and Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.